Загрузка...
Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
Pancreatic ductal adenocarcinoma is one of the most lethal types of tumour, and its incidence is rising worldwide. Although survival can be improved when these tumours are detected at an early stage, this cancer is usually asymptomatic, and the disease only becomes apparent after metastasis. The onl...
Сохранить в:
| Опубликовано в: : | Biomed Res Int |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5023838/ https://ncbi.nlm.nih.gov/pubmed/27689078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4873089 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|